NobleOak Life (NOL) AGM 2026 presentation summary
Event summary combining transcript, slides, and related documents.
AGM 2026 presentation summary
19 Nov, 2026Opening remarks and agenda
Agenda covered the Chair’s and CEO’s addresses, formal business, Q&A and close.
Formal business included consideration of the FY26 Financial Report, Directors’ Report and Auditor’s Report.
Financial performance review
FY26 in-force premiums were $549.2m, up 18% YoY; new business was $69.2m, up 9% YoY.
Underlying NPAT was $21.1m, up 15% YoY; reported NPAT was $14.1m, up 98% YoY.
Lapse rate was 12.5%, ~2.7ppts better than the industry average; in-force market share was 4.7% and new business market share was 14.1%.
Regulatory capital multiple was 183%, within target range; underlying diluted EPS was 22.04cps and reported diluted EPS was 14.77cps.
Embedded Value at 31 Dec 2025 was $217.7m, or $2.34 per share, up 9% YoY using an 8.5% discount rate.
Board and executive committee updates
Board members listed: Chair Sarah Brennan; CEO and Executive Director Anthony Brown; and Non-Executive Directors Andrew Boldeman, Andrew Gale, Inese Kingsmill and Alistair Muir.
Andrew Boldeman and Andrew Gale were re-elected; Alistair Muir, appointed by the Board since the previous AGM, was elected as a Director.
Latest events from NobleOak Life
- In-force premiums rose 18% and NPAT surged, with strong capital and robust FY27 growth outlook.NOL
H2 2026 - In-force premium up 19% and underlying NPAT up 11%, with strong growth outlook reaffirmed.NOL
H1 2026 - Strong growth, digital transformation, and all resolutions passed with overwhelming support.NOL
AGM 2025 - 20% in-force premium growth and 22% higher underlying NPAT, with strong FY26 outlook.NOL
H2 2025 - Strong growth, board renewal, and digital investment position for future success.NOL
AGM 2024 - In-force premiums up 22% and underlying NPAT up 19%, with strong market share gains.NOL
H2 2024 - 20% in-force premium growth and 11% NPAT increase, with strong capital and digital investment.NOL
H1 2025